Superficial keratectomy with mitomycin-C for the treatment of Salzmann's nodules

J Cataract Refract Surg. 2003 Jul;29(7):1302-6. doi: 10.1016/s0886-3350(02)01987-9.

Abstract

Purpose: To evaluate the success of treatment and prevention of recurrence of Salzmann's nodules by superficial keratectomy with intraoperative mitomycin-C (MMC).

Setting: Price Vision Group, Indianapolis, Indiana, USA.

Methods: This retrospective consecutive case series comprised 30 eyes of 25 patients who had superficial keratectomy with MMC between January 1997 and June 2000 at a large tertiary-care center.

Results: Twenty-four patients reported improvement in their symptoms. The remaining patient lost 1 line of visual acuity. Ninety-seven percent of eyes maintained or improved best corrected visual acuity. No patient had a recurrence of Salzmann's nodular degeneration over a mean follow-up of 28 months +/- 15 (SD) (range 4.0 days to 4.1 years).

Conclusion: Superficial keratectomy with MMC appears to be a valid and safe method for treating and preventing the recurrence of Salzmann's nodular degeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cicatrix / drug therapy
  • Cicatrix / pathology
  • Cicatrix / surgery*
  • Cornea / pathology
  • Cornea / surgery*
  • Corneal Diseases / drug therapy
  • Corneal Diseases / pathology
  • Corneal Diseases / surgery*
  • Female
  • Follow-Up Studies
  • Humans
  • Keratitis / drug therapy
  • Keratitis / pathology
  • Keratitis / surgery*
  • Male
  • Middle Aged
  • Mitomycin / therapeutic use*
  • Nucleic Acid Synthesis Inhibitors / therapeutic use*
  • Retrospective Studies
  • Treatment Outcome
  • Visual Acuity

Substances

  • Nucleic Acid Synthesis Inhibitors
  • Mitomycin